Opening book details…
Can I read Clinical and Histological Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma on EtoBox?
Clinical and Histological Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma by Pandey, Yadav; Matin, Aasiya; Broadfoot, Brannon; Kunthur, Anuradha is a Medicine article available to read on EtoBox.
What is Clinical and Histological Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma about?
Patients with renal cell carcinoma (RCC) often remain asymptomatic until the disease is advanced, with about 25% presenting at an advanced stage. We present a case of metastatic RCC treated with combination ipilimumab and nivolumab with complete radiological and pathological response. Currently, combination nivolumab and ipilimumab is a preferred option for intermediate- and poor-risk patients with clear cell stage IV RCC.
Who reads Clinical and Histological Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Pandey, Yadav; Matin, Aasiya; Broadfoot, Brannon; Kunthur, Anuradha
- Publisher
- Informa UK (Taylor & Francis); Taylor and Francis Ltd.; Informa UK Limited (ISSN 0899-8280)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Pandey, Yadav; Matin, Aasiya; Broadfoot, Brannon; Kunthur, Anuradha
Browse all works by Pandey, Yadav; Matin, Aasiya; Broadfoot, Brannon; Kunthur, Anuradha